Ophthalmology · Allentown, PA
NPI
1821275702
Since 2008
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5201 Hamilton Boulevard
Allentown, PA, 18106
Phone (610) 530-4444
Groups this clinician bills Medicare through
Medicare paid, 2024
$97K
1,438 services
Medicare patients, 2024
410
Average age 74
Drug cost, 2024
$402K
1,417 prescriptions
Company payments, 2025
$675
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Betsy P Luo was code 92014 (ophthalmological e&m), 290 times for 222 patients. In total Betsy P Luo billed 1,438 services in 40 codes, and Medicare paid $97K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 290 | 222 | $78.54 | $23K |
| 92012 Ophthalmological E&M | Office | 246 | 175 | $54.68 | $13K |
| 92083 Vision, Hearing, and Speech Services | Office | 106 | 93 | $38.70 | $4,103 |
| 92250 Angiography | Office | 94 | 74 | $25.21 | $2,370 |
| 92134 Computerized Ophthalmic Imaging | Office | 87 | 76 | $27.19 | $2,366 |
| 92133 Computerized Ophthalmic Imaging | Office | 73 | 65 | $22.74 | $1,660 |
| 92285 Standard X-ray | Office | 69 | 66 | $14.26 | $984 |
| 99214 Office E&M - Established | Office | 64 | 49 | $94.93 | $6,076 |
| 99213 Office E&M - Established | Office | 64 | 55 | $68.43 | $4,380 |
| 92002 Ophthalmological E&M | Office | 62 | 62 | $50.84 | $3,152 |
| 92004 Ophthalmological E&M | Office | 48 | 48 | $88.24 | $4,235 |
| 67820 Eye | Office | 38 | 27 | $15.62 | $594 |
| 67840 Eye | Facility | 29 | 27 | $108.69 | $3,152 |
| 76514 Ultrasound - Nonspecific | Office | 23 | 22 | $5.57 | $128 |
| 15823 Skin | Facility | 20 | 20 | $617.40 | $12K |
By year: 2022 $65K for 1,033 services; 2023 $77K for 1,080 services; 2024 $97K for 1,438 services.
Medicare prescription drug claims, 2024
In 2024, the drug Betsy P Luo prescribed most often to Medicare patients was Erythromycin (Erythromycin Base), with 243 prescriptions and refills. In total Betsy P Luo wrote 1,417 Medicare prescriptions that cost $402K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Erythromycin Erythromycin Base | 243 | 257 | 127 | $2,808 |
| Latanoprost Generic | 191 | 392 | 64 | $2,456 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 151 | 161 | 98 | $2,103 |
| Restasis Cyclosporine | 138 | 274 | 61 | $169K |
| Tobradex Tobramycin/Dexamethasone | 71 | 76 | 48 | $19K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 52 | 62 | 38 | $3,136 |
| Prednisolone Acetate Generic | 51 | 70 | 36 | $2,268 |
| Lumigan Bimatoprost | 51 | 83 | 13 | $22K |
| Brimonidine Tartrate Generic | 47 | 79 | 20 | $6,489 |
| Cyclosporine Generic | 44 | 87 | 17 | $21K |
| Timolol Maleate Generic | 41 | 95 | 16 | $1,692 |
| Ofloxacin Generic | 37 | 47 | 27 | $547 |
| Xiidra Lifitegrast | 32 | 64 | 15 | $41K |
| Dorzolamide Hcl Generic | 25 | 51 | Under 11 | $481 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 25 | 49 | Under 11 | $438 |
Brand drugs: 656 claims; generic drugs: 761 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Betsy P Luo $675 ($675 in general payments such as food, travel and fees) from 9 companies. The largest payer was Alcon Vision LLC with $291.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 7 | $291 |
| Tarsus Pharmaceuticals, Inc. TARS | 7 | $188 |
| Amgen Inc. AMGN | 3 | $69.79 |
| Biotissue Holdings Inc. | 1 | $24.97 |
| Ocular Therapeutix, Inc. OCUL | 1 | $22.02 |
| Dompe US, Inc. | 1 | $21.62 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $20.4 |
| Harrow Eye, LLC | 1 | $18.37 |
| Merz Pharmaceuticals, LLC | 1 | $18.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.